[1]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757-761.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
　WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(5):757-761.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
点击复制

心房颤动合并心力衰竭的射频消融治疗()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2019年5期
页码:
757-761
栏目:
综述
出版日期:
2019-08-25

文章信息/Info

Title:
Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure
作者:
吴彤1 高东来
1 高东来山西医科大学,山西 太原 030000;2.山西医科大学第二医院心内科,山西 太原 030000)
Author(s):
WU Tong1GAO Donglai 2
Shanxi Medical UniversityTaiyuan 030000 ShanxiChina2. Department of CardiologySecond Hospital of Shanxi Medical UniversityTaiyuan 030000ShanxiChina)
关键词:
心房颤动; 心力衰竭; 导管消融
Keywords:
Atrial fibrillation; Heart failure; Catheter ablation
DOI:
10.16806/j.cnki.issn.1004-3934.2019.05.023
摘要:
心房颤动和心力衰竭是心血管领域的高发病，二者常常合并存在，有着共同的复杂的病理生理学机制。恢复和维持窦性心律可明显改善心功能，但心力衰竭患者通常合并全身多脏器功能不全，本身对药物代谢性低，对抗心律失常药物的耐受性相对更差，多项研究表明导管消融可以降低心力衰竭合并心房颤动患者的远期死亡率，提高运动耐量，改善生存质量。
Abstract:
Atrial fibrillation and heart failure both have become major cardiovascular epidemics and are often detected in the same patient. Atrial fibrillation and heart failure have a common complex pathophysiological mechanism, and clinical outcomes are worse when they coexist. Restoring and maintaining sinus rhythm can improve cardiac function, but the benefits of rhythm control in heart failure patients may have been offset by side effects of antiarrhythmic drugs . However, c atheter ablation could achieve rhythm control, which is associated with reduction in hospitalization and mortality, enhancing exercise tolerance and improving patients’ live quality. Therefore, this review summarizes the current scientific evidence for catheter ablation in patients with atrial fibrillation and heart failure

参考文献/References:

[1].Stewart S ,Hart CL,Hole DJ,et al.A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study[J]. Am J Med,2002,113(5):359-364.
[2].Maisel WH,Stevenson LW.Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy[J]. Am J Cardiol,2003,91(6):2-8.
[3].马丽媛,吴亚哲,王文,等.《中国心血管病报告2017》要点解读[J].中国心血管杂志, 2018(1):3-6.
[4].Chugh SS,Blackshear JL,Shen WK,et al.Epidemiology and natural history of atrial fibrillation: clinical implications[J]. J Am Coll Cardiol,2001,37(2):371-378.
[5].Andrade J,Khairy P,Dobrev D,et al.The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms[J].Circ Res,2014, 114(9):1453-1468.
[6].Luong C,Barnes ME,Tsang TS.Atrial fibrillation and heart failure: cause or effect?[J].CurrHeartFail Rep, 2014,11(4):463-470.
[7].Schnee JM,Hsueh WA.Angiotensin Ⅱ,adhesion,and cardiac fibrosis[J]. Cardiovasc Res,2000,46(2):264-268.
[8].Zhao Z, Fefelova N, Shanmugam M,et al. Angiotensin Ⅱ induces afterdepolarizations via reactive oxygen species and calmodulin kinase Ⅱ signaling[J]. J Mol Cell Cardiol,2011,50(1):128-136.
[9].Mukharji J,Rehr RB,Hastillo A,et al.Comparison of atrial contribution to cardiac hemodynamics in patients with normal and severely compromised cardiac function[J].Clin Cardiol,2010,13(9):639-643.
[10].Bortone A,Pujadas-Berthault P,Karam N,et al.Catheter ablation in selected patients with depressed left ventricular ejection fraction and persistent atrial fibrillation unresponsive to current cardioversion[J]. Europace,2013,15(11):1574-1580.
[11].D’Souza A,Butcher KS,Buck BH.The multiple causes ofstroke?inatrial fibrillation: thinking broadly[J]. Can J Cardiol,2018,34(11):1503-1511.
[12].Dagres N,Varounis C,Gaspar T,et al.Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction.a systematic review and meta-analysis[J].J Card Fail,2011,17(11):964-970.
[13].Investigators TA.Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study[J].Circulation, 2004,13(6):1509-1513.
[14].Roy D,Talajic M,Nattel S,et al.Rhythm control versus rate control for atrial fibrillation and heart failure[J].N Engl J Med, 2008,358(25):2667-2677.
[15].Ha?ssaguerre M,Ja?s P,Shah DC,et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins[J]. N Engl J Med,1998,339(10):659-666.
[16].Calkins H,Hindricks G,Cappato R,et al.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary[J]. J Interv Card Electrophysiol,2017,50(1):1-55.
[17].Anselmino M,Matta M,D’Ascenzo F,et al.Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis[J].Circ Arrhythm Electrophysiol, 2014,7(6):1011-1018.
[18].Di BL,Mohanty P,Mohanty S,et al. Ablation vs. amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial[J].Circulation,2016,133(17):1637-1644.
[19].Marrouche NF, Brachmann J, Andresen D, et al.Catheter ablation for atrial fibrillation with heart failure[J]. N Engl J Med,2018,378(5):417-427.
[20].Wachter R.Atrial fibrillation?as a comorbidity of?heart failure[J]. Internist (Berl), 2018,59(5):415-419.
[21].Kelly J,Mentz R,Mebazaa A,et al.Patient selection in heart failure with preserved ejection fraction clinical trials[J]. J Am Coll Cardiol,2015,65(16):1668-1682.
[22].Zakeri R,Chamberlain AM,Roger VL,et al.Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: A community-based study[J]. Circulation,2013,128(10):1085-1093.
[23]. Vermond RA,Geelhoed B,Verweij N,et al.Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality[J]. J Am Coll Cardiol,2015,66(9):1000-1007.
[24].Cha YM,Wokhlu A,Asirvatham SJ,et al. Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function[J].Circ Arrhythm Electrophysiol,2011,4(5):724-732.
[25].Black-Maier E, Ren X, Steinberg BA, et al.Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction[J]. Heart Rhythm,2018,15(5):651-657.
[26].Habibi M,Lima JA,Gucuk Ipek E,et al.The association of baseline left atrial structure and function measured with cardiac magnetic resonance and pulmonary vein isolation outcome in patients with drug-refractory atrial fibrillation [J]. Heart Rhythm,2016,13(5):1037-1044.
[27].Mukherjee RK,Williams SE,Niederer SA,et al.Atrial fibrillation ablation in patients with heart failure: one size does not fit all [J]. Arrhythm Electrophysiol Rev,2018,7(2):84-90.
[28].McGann C,Akoum N,Patel A,et al.Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI[J]. Circ Arrhythm Electrophysiol,2014,7(1):23-30.
[29].Stiles MK,Sanders P,Lau DH.Targeting the substrate in ablation of persistent atrial fibrillation: recent lessons and future directions[J]. Front Physiol,2018,9:1158.
[30].Rienstra M,Hobbelt AH,Alings M,et al.Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial[J].Eur Heart J,2018,39(32):2987-2996.
[31].Anselmino M,Matta M,Castagno D,et al.Catheter ablation of atrial fibrillation in chronic heart failure: state-of-the-art and future perspectives[J]. Europace,2016,18(5):638-647.
[32]. Cha YM,Wokhlu A,Asirvatham SJ,et al.Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function[J]. Circ Arrhythm Electrophysiol,2011,4(5):724-732.
[33].Black-Maier E,Ren X,Steinberg BA,et al.Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction[J].Heart Rhythm,2018,15(15):651-657.
[34].January CT,Wann LS,Calkins H,et al.2019AHA/ACC/HRSfocusedupdateof the2014AHA/ACC/HRSguidelinefor themanagementof patientswithatrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart rhythm society[J]. Heart Rhythm,2019,Jan 28.pii: S1547-5271(19)30037-2.doi:10.1016/j.hrthm.2019.01.024.
[35].Friberg L,Tabrizi F,Englund A.Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries[J]. Eur Heart J,2016,37(31):2478-2487.
[36].Richter S,di Biase L,Hindricks G.Atrial fibrillation ablation in heart failure[J]. EurHeartJ,2019,40(8):663-671.

相似文献/References:

[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
　HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(5):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
　DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(5):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
　DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(5):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[4]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
　ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[5]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
　ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[6]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
　HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[7]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
　WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[8]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
　LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(5):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[9]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
　ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(5):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[10]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
　LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(5):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[11]鲁星琴 莫乔莹 陈凤梅 姚亚丽.睡眠呼吸障碍与心力衰竭并发心房颤动的相关性研究现状[J].心血管病学进展,2020,(2):182.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.021]
　LU Xingqin,MO Qiaoying,CHENG Fengmei,et al.Research Status of Association Between Sleep-disordered Breathing and Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2020,(5):182.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.021]
[12]史云聪,王立立 郭艺芳.维生素D与心血管疾病相关性研究进展[J].心血管病学进展,2020,(8):826.[doi:10.16806/j.cnki.issn.1004-3934.20.08.011]
　SHI YuncongWANG LiliGUO Yifang.Vitamin D And Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(5):826.[doi:10.16806/j.cnki.issn.1004-3934.20.08.011]
[13]李英  刘兴鹏.常见心血管病服药依从性[J].心血管病学进展,2020,(10):1016.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.000]
　LI Ying,LIU Xingpeng.Medication Adherence For Common Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(5):1016.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.000]
[14]刘玉辉 王盼盼 陈椿.心房颤动性心肌病临床研究进展[J].心血管病学进展,2020,(12):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
　LIU Yuhui,WANG Panpan,CHEN Chun.Atrial Fibrillation-induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(5):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
[15]徐尧 蔡衡 李洪仕.心房颤动合并心力衰竭的导管消融治疗[J].心血管病学进展,2021,(4):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
　XU Yao,CAI Heng,LI Hongshi.Role of Radiofrequency Ablation in Patients with Atrial Fibrillation and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(5):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
[16]徐尧 蔡衡 李洪仕.射频消融与药物治疗对心房颤动合并心力衰竭患者的疗效差异比较[J].心血管病学进展,2022,(3):274.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[17]乔宝 魏述建.心房衰竭的临床研究进展[J].心血管病学进展,2024,(1):57.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.015]
　QIAO Bao,WEI Shujian.Progress of Clinical Research on Atrial Failure[J].Advances in Cardiovascular Diseases,2024,(5):57.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.015]

更新日期/Last Update: 2019-12-24